IMS Health is the one global source for pharmaceutical market intelligence, providing critical information, analysis and services that drive decisions and shape strategies. Operating in more than 100 countries, IMS is the world’s leading provider of information solutions to the pharmaceutical and healthcare industries. With $1.8 billion in 2005 revenue and more than 50 years of industry experience, IMS offers leading-edge business intelligence products and services that are integral to clients’ day-to-day operations, including marketing effectiveness solutions for prescription and OTC pharmaceutical products, sales force effectiveness solutions to increase pharmaceutical sales force productivity, and consulting and customized services that turn information into actionable insights.

ZS Associates is a global management consulting firm specializing in sales and marketing strategy, operations and execution. ZS helps companies achieve sales success by delivering both issue-specific solutions and large-scale business transformations, and is expert in go-to-market and sales force strategy as well as downstream implementation.  ZS combines sales and marketing expertise with rigorous, fact-based analysis to help companies make and execute effective decisions. Founded in 1983, ZS has more than 800 professionals serving multinational, midsize and entrepreneurial clients from 14 offices worldwide, with a particular emphasis on the healthcare sector.

URL
www.zsassociates.com

Gold Sponsors:

Founded in 1995, Equinox Group is a specialized consulting firm that assesses the commercial outlook for drugs to help pharmaceutical and biotechnology companies make better business decisions. We offer innovative analysis, cutting-edge forecasting techniques, and substantial experience to help our clients evaluate opportunities in all therapeutic areas.

The company is a leader in the art of new drug forecasting and places special emphasis on product and total market forecasting. Equinox Group’s forecast models offer unique features that include:  providing patient shares based on a valid and transparent forecast engine and allowing users to easily conduct rapid updates and robust sensitivity analysis. The company also offers market structure and patient flow mapping as well as conducts primary market research with physicians, payers, and patients.

The mission of Oracle's Enterprise Performance Management (EPM) Global Business Unit is to maximize Oracle's market share in Business Intelligence (BI) and EPM by establishing Oracle as the recognized thought leader in the category, empowering sales and marketing channels, supporting partners and sharing best practices with customers.

Oracle's Crystal Ball is a full suite of Microsoft Excel-based applications for Monte Carlo simulation, time-series forecasting, optimization and real options analysis. Crystal Ball transforms spreadsheets into dynamic models that solve almost any problem involving uncertainty, variability and risk.

Workshop Sponsors:

SAS is the leader in business intelligence and analytical software and services. For more than 30 years, SAS solutions have assured accurate, consistent and reliable analysis of research and business information across the life sciences industry. Life sciences organizations use SAS forecasting software to continuously improve operational performance across all business departments. SAS is the de facto standard for the analysis and reporting of clinical data and SAS solutions are used at 100 percent of the pharmaceutical companies on the FORTUNE Global 500. For three decades, SAS has been giving customers around the world THE POWER TO KNOW®.

Panel Sponsor:

Exhibitors:

Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, commercialize and manufacture biotherapeutics that address significant unmet medical needs. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions and over 50 projects in the pipeline. The company is the leading provider of anti-tumor therapeutics in the United States. With its strength in all areas of the drug development process — from research and development to manufacturing and commercialization — Genentech continues to transform innovative science into breakthrough therapies for patients.